Expanding Platforms For Efficacious Mrna Therapeutics

  Address - Netherlands

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10097195

  Document Type - Tender Notices

Description - Status : Grant agreement signedOverall budget : € 15 010 087,50EU contribution : € 14 931 337,50The overall objective of expert is to create an off-the-shelf mrna-delivering nanomedicine platform that is manufactured via a quality-by-design (qbd) approach with precise nanoparticle characterization and specifications that meet the requirements for gmp scaling up and clinical translation. As proof-of-concept we will perform a first-in-man clinical study for an intratumorally administered immunostimulatory mrna-nanomedicine in cancer patients. The work focuses on the three critical elements of the call innovation platforms for advanced therapies of the future 1. Expert investigates mrnas as

Mt Ref Id - 10097195

Deadline - Aug 31, 2024